September 26, 2018
Vicore Pharma postpones publication of interim report
Media
September 24, 2018
Altimmune Announces $4.9 million Registered Direct Offering of Common Stock
September 24, 2018
Altimmune Awarded $2.5 Million in Additional BARDA Funding to Support NasoShield™ Development
September 19, 2018
BONESUPPORT highlights significant strategic progress at Capital Market Days in Stockholm and London
September 18, 2018
Strongbridge Biopharma plc to Participate in Two Upcoming Healthcare Investor Conferences
September 18, 2018
First patient starts treatment with Ygalo® in Oncopeptides’ Phase II study BRIDGE in RRMM patients with renal impairment
September 18, 2018
Vicore publishes prospectus and new financial information contained in the prospectus
September 18, 2018
BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program
September 17, 2018
Vicore Pharma strengthens team with two key hires to support focus on rare lung disease
September 13, 2018
GenSight Biologics provides an update on the clinical and regulatory pathways for GS010